Effects of Topical or Intravitreal Application of Anti-Vascular Endothelial Growth Factor on Density of Intestinal Blood Vessels of Mice
<i>Background and Objectives:</i> Anti-vascular endothelial growth factor (anti-VEGF) therapy has become the first-line treatment for diabetic macular edema. However, it is still not clear whether anti-VEGF agents act on systemic blood vessels. The aim of this study is to determine wheth...
Main Authors: | Atsushi Ichio, Masahiko Sugimoto, Yuhki Koike, Yuji Toiyama, Mineo Kondo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1648-9144/59/4/809 |
Similar Items
-
The Association of Intravitreal Injections of Different Anti-Vascular Endothelial Growth Factor with Systemic Outcomes in Diabetic Patients
by: Eugene Yu-Chuan Kang, et al.
Published: (2023-03-01) -
Human Herpesvirus-6 corneal Endotheliitis after intravitreal injection of Ranibizumab
by: Masahiro Onda, et al.
Published: (2019-01-01) -
Association between Obstetric Complications and Intravitreal Anti-Vascular Endothelial Growth Factor Agents or Intravitreal Corticosteroids
by: Inès Ben Ghezala, et al.
Published: (2022-08-01) -
Systemic Outcomes of Intravitreal Injections of Dexamethasone and Anti-Vascular Endothelial Growth Factor
by: Tzu-Yi Lin, et al.
Published: (2023-02-01) -
Case of Repeated Full-Thickness Macular Hole Formations and Spontaneous Closure following Intravitreal Bevacizumab Treatment for Central Retinal Vein Occlusion
by: Rika Furukawa, et al.
Published: (2022-11-01)